GCN5 expression and function therefore accelerates growth of MYC-overexpressing AML, Burkitt’s lymphoma (BL), hepatocellular carcinoma (HCC), colon and non-small cell lung cancer (NSCLC) in cellular systems and, shown in BL, HCC and NSCLC, in vivo mouse models [97, 104–109]. This evidence concerns the gene KAT2B and acute myeloid leukemia.